Efficient gene silencing in metastatic tumor by siRNA formulated in surface-modified nanoparticles.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Controlled Release

• Publication date

  2008-02-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.JCONREL.2007.11.002PMID 18083264PMCID PMC2692667
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor-targeted delivery of siRNA by self-assembled nanoparticles.

  2008cited by this paper
• Preparation and Biologic Evaluation of a Novel Radioiodinated Benzylpiperazine, 123I-MEL037, for Malignant Melanoma

  2007cited by this paper
• Non-viral is superior to viral gene delivery.

  2007cited by this paper
• Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system.

  2007cited by this paper
• Mechanistic studies of sequential injection of cationic liposome and plasmid DNA.

  2006cited by this paper
• Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells.

  2006influential reference
• Recombinant adeno-associated virus mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of Epstein-Barr virus encoded LMP-1.

  2006cited by this paper
• Surface‐Modified LPD Nanoparticles for Tumor Targeting

  2006cited by this paper
• Tumor Growth Inhibition by Simultaneously Blocking Epidermal Growth Factor Receptor and Cyclooxygenase-2 in a Xenograft Model

  2005cited by this paper
• Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo.

  2005cited by this paper
• Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma.

  2005cited by this paper
• Gene silencing in primary and metastatic tumors by small interfering RNA delivery in mice: quantitative analysis using melanoma cells expressing firefly and sea pansy luciferases.

  2005cited by this paper
• Anisamide‐targeted stealth liposomes: A potent carrier for targeting doxorubicin to human prostate cancer cells

  2004cited by this paper
• Nanoparticle and targeted systems for cancer therapy.

  2004cited by this paper
• In vivo gene transfer via intravenous administration of cationic lipid–protamine–DNA (LPD) complexes

  1997cited by this paper
• CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract.

  1997cited by this paper
• Organ-specific modulation of steady-state mdr gene expression and drug resistance in murine colon cancer cells.

  1994cited by this paper

• Knocking on Cells’ Door: Strategic Approaches for miRNA and siRNA in Anticancer Therapy

  2025cites this paper
• Recent Advances in Lipid Nanoparticles: Nucleic Acid Therapeutics and Targeting Strategies.

  2025cites this paper
• Red Blood Cell Membrane Vesicles for siRNA Delivery: A Biocompatible Carrier With Passive Tumor Targeting and Prolonged Plasma Residency

  2025cites this paper
• Small Interfering RNA Drug Delivery System in Cancer

  2024cites this paper
• Unlocking the potential of nanocarrier-mediated mRNA delivery across diverse biomedical frontiers: A comprehensive review.

  2024cites this paper
• Therapeutic effect of E-Lip-siRNA-sFlt1 on pre-eclampsia: targeted gene silencing and improved pregnancy outcomes.

  2024cites this paper
• Lipid nanovehicles overcome barriers to systemic RNA delivery: Lipid components, fabrication methods, and rational design

  2023cites this paper
• Blood Clot Scaffold Loaded with Liposome Vaccine and siRNAs Targeting PD-L1 and TIM-3 for Effective DC Activation and Cancer Immunotherapy.

  2022cites this paper
• Short Fibre Reinforced Cementitious Composites and Ceramics

  2021cites this paper
• Highly Bright AIE Nanoparticles by Regulating the Substituent of Rhodanine for Precise Early Detection of Atherosclerosis and Drug Screening

  2021cites this paper
• Lipids and Lipid Derivatives for RNA Delivery.

  2021cites this paper
• Nanomedicine-based delivery strategies for nucleic acid gene inhibitors in inflammatory diseases.

  2021cites this paper
• Liposomes: An emerging approach for treatment of cancer.

  2021cites this paper
• A review on liposome-based therapeutic approaches against malignant melanoma.

  2021cites this paper
• The importance of co‐delivery of nanoparticle‐siRNA and anticancer agents in cancer therapy

  2021cites this paper
• Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery

  2020cites this paper
• Surface Modification of Bio-polymeric Nanoparticles and Its Applications

  2020cites this paper
• Development of a carrier system containing hyaluronic acid and protamine for siRNA delivery in the treatment of melanoma

  2020cites this paper
• Proof of concept studies for siRNA delivery by nonionic surfactant vesicles: in vitro and in vivo evaluation of protein knockdown

  2019cites this paper
• Improved Efficacy in a Fabry Disease Model Using a Systemic mRNA Liver Depot System as Compared to Enzyme Replacement Therapy

  2019cites this paper
• Anisamide‐targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice

  2019cites this paper
• Nanomedicine-combined immunotherapy for cancer.

  2019cites this paper
• Liposomes for drug delivery in stroke.

  2019cites this paper
• Hyaluronic Acid as an Emerging Technology Platform for Silencing RNA Delivery

  2019cites this paper
• Tumor-specific delivery of therapeutic siRNAs by anti-EGFR immunonanoparticles

  2018cites this paper
• Role Of MIR-489 In HER2 Positive Breast Cancer

  2018cites this paper
• Autophagy, Cell Viability, and Chemoresistance Are Regulated By miR-489 in Breast Cancer

  2018cites this paper
• Small molecules convey big messages: Boosting non-viral nucleic acid delivery with low molecular weight drugs

  2017cites this paper
• Application of Polyionic Macromolecules in Micro Flow Syntheses of Nanoparticles

  2017cites this paper
• Selective targeting and therapy of metastatic and multidrug resistant tumors using a long circulating podophyllotoxin nanoparticle.

  2017cites this paper
• Effect of Liposomes with Different Double Arms Polyethyleneglycol on Hepatic Metastasis Model Mice and Evaluation Using a Fluorescent Imaging Device.

  2017cites this paper
• Targeting Nanocarriers with Anisamide: Fact or Artifact?

  2017cites this paper
• Targeted Delivery of siRNA Therapeutics to Malignant Tumors

  2017cites this paper
• Application Potential of Engineered Liposomes in Tumor Targeting

  2017cites this paper
• Nanomedicine strategies for sustained, controlled and targeted treatment of cancer stem cells.

  2016cites this paper
• Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system

  2016cites this paper
• A novel double-negative feedback loop between miR-489 and the HER2-SHP2-MAPK signaling axis regulates breast cancer cell proliferation and tumor growth

  2016cites this paper
• Lipopolyplex for Therapeutic Gene Delivery and Its Application for the Treatment of Parkinson’s Disease

  2016influential citation
• Therapeutic effect for liver-metastasized tumor by sequential intravenous injection of anionic polymer and cationic lipoplex of siRNA

  2016cites this paper
• Findings questioning the involvement of Sigma-1 receptor in the uptake of anisamide-decorated particles.

  2016cites this paper
• A Glu-urea-Lys Ligand-conjugated Lipid Nanoparticle/siRNA System Inhibits Androgen Receptor Expression In Vivo

  2016cites this paper
• Engineering biodegradable micelles of polyethylenimine-based amphiphilic block copolymers for efficient DNA and siRNA delivery.

  2016cites this paper
• Sigma receptor-mediated targeted delivery of anti-angiogenic multifunctional nanodrugs for combination tumor therapy.

  2016cites this paper
• Anisamide-targeted gold nanoparticles for siRNA delivery in prostate cancer - synthesis, physicochemical characterisation and in vitro evaluation.

  2016cites this paper
• A novel, anisamide-targeted cyclodextrin nanoformulation for siRNA delivery to prostate cancer cells expressing the sigma-1 receptor.

  2016cites this paper
• Membrane Microdomain Structures of Liposomes and Their Contribution to the Cellular Uptake Efficiency into HeLa Cells.

  2016cites this paper
• siRNA Lipid Nanoparticle Potently Silences Clusterin and Delays Progression When Combined with Androgen Receptor Cotargeting in Enzalutamide-Resistant Prostate Cancer

  2015cites this paper
• siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes

  2015cites this paper
• SAINT-liposome-polycation particles, a new carrier for improved delivery of siRNAs to inflamed endothelial cells.

  2015cites this paper
• Nanomedicine as an emerging platform for metastatic lung cancer therapy

  2015cites this paper
• Delivery of RNA nanoparticles into colorectal cancer metastases following systemic administration.

  2015cites this paper
• Non-viral therapeutic approaches to ocular diseases: An overview and future directions.

  2015cites this paper
• PEGylated hyaluronic acid-modified liposomal delivery system with anti-γ-glutamylcyclotransferase siRNA for drug-resistant MCF-7 breast cancer therapy.

  2015cites this paper
• Comparison of VEGF gene silencing efficiencies of chitosan and protamine complexes containing shRNA

  2014cites this paper
• Enhanced gene delivery efficiency of cationic liposomes coated with PEGylated hyaluronic acid for anti P-glycoprotein siRNA: a potential candidate for overcoming multi-drug resistance.

  2014cites this paper
• Lipid-calcium phosphate nanoparticles for delivery to the lymphatic system and SPECT/CT imaging of lymph node metastases.

  2014cites this paper
• Increased tumor distribution and expression of histidine-rich plasmid polyplexes

  2014cites this paper
• Durable Expression of Minicircle DNA-Liposome-Delivered Androgen Receptor cDNA in Mice with Hepatocellular Carcinoma

  2014cites this paper
• Composite nanoparticles for gene delivery.

  2014cites this paper
• Development and clinical applications of siRNA-encapsulated lipid nanoparticles in cancer

  2014cites this paper
• Anticancer use of nanoparticles as nucleic acid carriers.

  2014cites this paper
• Membrane/core nanoparticles for delivery of therapeutic nucleic acid

  2013cites this paper
• Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis.

  2013cites this paper
• Lipophilic-formulated gold porphyrin nanoparticles for chemotherapy.

  2013cites this paper
• Recent Trends in Multifunctional Liposomal Nanocarriers for Enhanced Tumor Targeting

  2013cites this paper
• Comparison of anti-EGFR-Fab’ conjugated immunoliposomes modified with two different conjugation linkers for siRNa delivery in SMMC-7721 cells

  2013cites this paper
• Incorporation of histone derived recombinant protein for enhanced disassembly of core-membrane structured liposomal nanoparticles for efficient siRNA delivery.

  2013cites this paper
• LCP nanoparticle for tumor and lymph node metastasis imaging

  2013cites this paper
• Antibody-targeted immunoliposomes for cancer treatment.

  2013cites this paper
• Targeted siRNA delivery by anti-HER2 antibody-modified nanoparticles of mPEG-chitosan diblock copolymer

  2013cites this paper
• Gene Therapy: Technologies and Applications

  2013cites this paper
• Lipid Nanoparticles for the Delivery of Nucleic Acids

  2013cites this paper
• Lipid nanoparticles encapsulating siRNAs against the androgen receptor to treat advanced prostate cancer

  2013cites this paper
• Emerging Potential of Nanoparticles for the Treatment of Solid Tumors and Metastasis

  2013cites this paper
• Chemical vectors for gene delivery

  2013cites this paper
• Needle-free gene delivery through the skin: an overview of recent strategies.

  2013cites this paper
• Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy.

  2013cites this paper
• Synergetic Targeted Delivery of Sleeping‐Beauty Transposon System to Mesenchymal Stem Cells Using LPD Nanoparticles Modified with a Phage‐Displayed Targeting Peptide

  2013cites this paper
• A novel dendritic nanocarrier of polyamidoamine-polyethylene glycol-cyclic RGD for “smart” small interfering RNA delivery and in vitro antitumor effects by human ether-à-go-go-related gene silencing in anaplastic thyroid carcinoma cells

  2013cites this paper
• Emerging nanodelivery strategies of RNAi molecules for colon cancer therapy: preclinical developments.

  2012cites this paper
• Supramolecular assemblies in functional siRNA delivery: where do we stand?

  2012cites this paper
• Hepatocellular carcinoma targeting effect of PEGylated liposomes modified with lactoferrin.

  2012cites this paper
• A review of nanocarriers for the delivery of small interfering RNA.

  2012cites this paper
• Intelligent design of multifunctional lipid-coated nanoparticle platforms for cancer therapy.

  2012cites this paper
• Systemic delivery of siRNA via LCP nanoparticle efficiently inhibits lung metastasis.

  2012cites this paper
• Lipid-based vectors for siRNA delivery

  2012cites this paper
• Trp2 peptide vaccine adjuvanted with (R)-DOTAP inhibits tumor growth in an advanced melanoma model.

  2012cites this paper
• Anisamide-targeted cyclodextrin nanoparticles for siRNA delivery to prostate tumours in mice.

  2012cites this paper
• Recent advances in nonviral vectors for gene delivery.

  2012cites this paper
• EGFR-specific PEGylated immunoliposomes for active siRNA delivery in hepatocellular carcinoma.

  2012cites this paper
• Ligands located within a cholesterol domain enhance gene delivery to the target tissue.

  2012influential citation
• The effect of cholesterol domains on PEGylated liposomal gene delivery in vitro.

  2011cites this paper
• RNAi-mediated gene silencing in tumour tissue using replication-competent retroviral vectors

  2011cites this paper
• Targeted siRNA delivery to diseased microvascular endothelial cells—Cellular and molecular concepts

  2011cites this paper
• Lipid-based cancer vaccines

  2011cites this paper
• Illuminating the Gateway of Gene Silencing: Perspective of RNA Interference Technology in Clinical Therapeutics

  2011cites this paper
• Non-viral nucleic acid delivery: key challenges and future directions.

  2011cites this paper
• WITHDRAWN: Quantum dot-tumor targeting peptide conjugates for in vivo imaging of siRNA expression constructs delivery and silencing in tumors.

  2011cites this paper
• More effective nanomedicines through particle design.

  2011cites this paper
• Novel siRNA lipoplexes : their targeted and untargeted delivery to mammalian cells in culture.

  2011cites this paper